Association between resting heart rate and cardiovascular mortality: Evidence from a meta-analysis of prospective studies

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 15329-15339

  Li, Yuechun ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiovascular mortality; Meta analysis; Resting heart rate

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR MORTALITY; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION PROCESSING; META ANALYSIS (TOPIC); METHODOLOGY; PROSPECTIVE STUDY; RESTING HEART RATE; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW (TOPIC);

EID: 84946543383     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kannel WB, Kannel C, Paffenbarger RS Jr and Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-1494.
2. Zuanetti G, Mantini L, Hernandez-Bernal F, Barlera S, di Gregorio D, Latini R and Maggioni AP. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study. Eur Heart J 1998; 19 Suppl F: F19-26.
3. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC and Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol 2010; 105: 905-911.
4. Carnethon MR, Golden SH, Folsom AR, Haskell W and Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987- 1998. Circulation 2003; 107: 2190-2195.
5. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R and Mancia G. Heart rate as marker of sympathetic activity. J Hypertens 1998; 16: 1635-1639.
6. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP and Louridas GE. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 2008; 126: 302-312.
7. Ingwall JS and Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2004; 95: 135-145.
8. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M; Heart Rate Working Group. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007; 50: 823-830.
9. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008; 372: 817-821.
10. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-41.
11. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, Sands A, Hu FB and Liu L. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ 2013; 346: e8539.
12. Greenland S and Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
13. Orsini N and Bellocco R. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40-57.
14. Orsini N, Li R, Wolk A, Khudyakov P and Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
15. Larsson SC, Giovannucci E and Wolk A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2007; 99: 64-76.
16. Chen H, Qin S, Wang M, Zhang T and Zhang S. Association between cholesterol intake and pancreatic cancer risk: Evidence from a metaanalysis. Sci Rep 2015; 5: 8243.
17. Higgins JP and Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
18. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
19. Higgins JP and Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-1682.
20. Tobias A. Assessing the in fluence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 47: 15-17.
21. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629- 634.
22. Gillum RF, Makuc DM and Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1991; 121: 172-177.
23. Benetos A, Rudnichi A, Thomas F, Safar M and Guize L. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999; 33: 44- 52.
24. Kristal-Boneh E, Silber H, Harari G and Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21: 116-124.
25. Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P and Aromaa A. Heart rate and mortality. J Intern Med 2000; 247: 231-239.
26. Seccareccia F, Pannozzo F, Dima F, Minoprio A, Menditto A, Lo Noce C, Giampaoli S; Malattie Cardiovascolari Aterosclerotiche Istituto Superiore di Sanita Project. Heart rate as a predictor of mortality: the MATISS project. Am J Public Health 2001; 91: 1258-1263.
27. Cheng YJ, Macera CA, Church TS and Blair SN. Heart rate reserve as a predictor of cardiovascular and all-cause mortality in men. Med Sci Sports Exerc 2002; 34: 1873-1878.
28. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, Metoki H, Ohmori K, Hoshi H, Hashimoto J, Satoh H, Tsuji I and Imai Y. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004; 17: 1005-1010.
29. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Elliott P, Ueshima H and Group NR. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004; 147: 1024- 1032.
30. Kizilbash MA, Daviglus ML, Dyer AR, Garside DB, Hankinson AL, Yan LL, Tian L, Van L, Wang R and Greenland P. Relation of heart rate with cardiovascular disease in normal-weight individuals: the Chicago Heart Association Detection Project in Industry. Prev Cardiol 2008; 11: 141-147.
31. Tverdal A, Hjellvik V and Selmer R. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years. Eur Heart J 2008; 29: 2772-2781.
32. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A and Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159: 612-619, e613.
33. Nauman J, Nilsen TI, Wisloff U and Vatten LJ. Combined effect of resting heart rate and physical activity on ischaemic heart disease: mortality follow-up in a population study (the HUNT study, Norway). J Epidemiol Community Health 2010; 64: 175-181.
34. Jensen MT, Marott JL and Jensen GB. Elevated resting heart rate is associated with greater risk of cardiovascular and all-cause mortality in current and former smokers. Int J Cardiol 2011; 151: 148-154.
35. Jouven X, Escolano S, Celermajer D, Empana JP, Bingham A, Hermine O, Desnos M, Perier MC, Marijon E and Ducimetiere P. Heart rate and risk of cancer death in healthy men. PLoS One 2011; 6: e21310.
36. Legeai C, Jouven X, Tafflet M, Dartigues JF, Helmer C, Ritchie K, Amouyel P, Tzourio C, Ducimetiere P and Empana JP. Resting heart rate, mortality and future coronary heart disease in the elderly: the 3C Study. Eur J Cardiovasc Prev Rehabil 2011; 18: 488-497.
37. Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT-Study Group. Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information? Eur J Prev Cardiol 2012; 19: 275-284.
38. Woodward M, Webster R, Murakami Y, Barzi F, Lam TH, Fang X, Suh I, Batty GD, Huxley R and Rodgers A. The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts. Eur J Prev Cardiol 2012; 21: 719- 726.
39. Saxena A, Minton D, Lee DC, Sui X, Fayad R, Lavie CJ and Blair SN. Protective role of resting heart rate on all-cause and cardiovascular disease mortality. Mayo Clin Proc 2013; 88: 1420-1426.
40. Ho JE, Larson MG, Ghorbani A, Cheng S, Coglianese EE, Vasan RS and Wang TJ. Longterm cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc 2014; 3: e000668.
41. Ryu M, Gombojav B, Nam CM, Lee Y and Han K. Modifying effects of resting heart rate on the association of binge drinking with all-cause and cardiovascular mortality in older Korean men: the Kangwha Cohort Study. J Epidemiol 2014; 24: 274-280.
42. Jensen MT, Marott JL, Allin KH, Nordestgaard BG and Jensen GB. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. Eur J Prev Cardiol 2012; 19: 102-108.
43. MunafoMR and Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444.